跳至主要内容
临床试验/NCT03341169
NCT03341169Unknown不适用

Impact of Perioperative Treatment With Intravenous Glutamine on Myocardial Protection in Cardiac Surgery Patients With Aortic Stenosis

Yonsei University1 个研究点 分布在 1 个国家目标入组 108 人开始时间: 2018年3月20日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
108
试验地点
1
主要终点
degree of myocardial damage with CK-MB (Creatine Kinase MB lsoenzyme)

研究概览

简要总结

The purpose of this study is to confirm if myocardial protection effect can be obtained by intravenous administration of glutamine in patients undergoing aortic valve replacement with severe aortic stenosis (who are at high risk for ischemia-reperfusion injury). As a prospective double blinded randomized placebo-controlled trial, the investigators detect and compare the degree of myocardial damage(with CK-MB and Troponin T) and myocardial protection (through hsp 70 expression in atrial tissue), cardiovascular index, inflammatory reaction, and clinical manifestation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients with between 20 and 80 years scheduled for aortic valve replacement alone or combined surgery including aortic valve replacement due to severe aortic valve stenosis

排除标准

  • Patients with renal insufficiency (eGFR 60 ml / min / 1.73 m 2 or less)
  • patients who are considering surgery for coronary artery disease or who have a stenosis> 70%
  • hemodynamically unstable patients undergoing emergency surgery or patients with intra-aortic balloon pump insertion
  • patients unable to make their own decisions, illiterate, foreigners
  • severe metabolic acidosis
  • pulmonary edema
  • history of myocardial infarction
  • elevation of total bilirubin or AST / ALT
  • Patients higher than normal, weighing more than 80 kg
  • with evidence of infection
  • pregnant and lactating women

研究组 & 干预措施

Glutamine

Experimental

Intravenous glutamine infusion perioperatively for 18 hours (8 hours before surgery and 10 hours after induction of anesthesia)

干预措施: N(2)-L-Alanine L-Glutamine dipeptide (Drug)

Placebo

Placebo Comparator

干预措施: placebo (0.9% NaCl (normal saline)) (Drug)

结局指标

主要结局

degree of myocardial damage with CK-MB (Creatine Kinase MB lsoenzyme)

时间窗: 48 hours after surgery

Troponin-T(Tn-T) level

时间窗: 24 hours after surgery

次要结局

  • IL-6(10 minutes after ICU(intensive care unit) entrance)
  • Free fatty acid(10 minutes after ICU(intensive care unit) entrance)
  • CRP(24 hours after surgery)
  • cardiovascular index(24 hours after surgery)
  • occurrence of sternal infections(Within 30 days postoperatively)
  • mortality(During hospitalization regardless of length of stay or within 30 days of surgery if discharged)
  • occurrence of cardiovascular complications(up to 1 year)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Impact of Perioperative Treatment With Intravenous... | 临床试验